The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effectiveness and safety in very elderly patients treated by bevacizumab (BV) plus chemotherapy in first-line therapy of metastatic colorectal cancer: Results of ETNA, a French cohort study.
Denis Smith
Disclosure not yet available
Magali Rouyer
Disclosure not yet available
P. Noize
Disclosure not yet available
Régis Lassalle
Disclosure not yet available
Olivier Bernard
Disclosure not yet available
Franck Burki
Disclosure not yet available
Pierre Guichard
Disclosure not yet available
Alain Ravaud
Disclosure not yet available
Nicholas Moore
Disclosure not yet available
Annie Fourrier-R├ęglat
Disclosure not yet available